Universal Bone Densitometry Screening Combined with Alendronate Therapy for Those Diagnosed with Osteoporosis Is Highly Cost‐Effective for Elderly Women
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Objectives: To investigate the cost‐effectiveness of universal bone densitometry in women aged 65 and older combined with alendronate treatment for those diagnosed with osteoporosis (femoral neck T‐score ≤−2.5). Design: A Markov model with a lifetime time horizon and eight health states (no fracture, distal forearm fracture, radiographic (but clinically inapparent) vertebral fracture, clinical vertebral fracture, hip fracture, hip and vertebral fracture, and other fractures), using the societal perspective. Setting: Women living independently and those in nursing homes. Participants: Caucasian women aged 65, 75, 85, or 95. Intervention: Bone densitometry of the hip, with 5 years of alendronate therapy for those found to have osteoporosis versus no intervention (densitometry or drug therapy). Measurements: Lifetime accumulated quality adjusted life years (QALYs), costs, and incremental cost‐effectiveness ratios. Results: The cost per QALY gained for the screen‐and‐treat strategy was $43,000 per QALY gained for 65‐year‐old women and $5,600 per QALY gained for 75‐year‐old women. For 85‐ and 95‐year‐old women, the screen‐and‐treat strategy was cost saving. Sensitivity analyses showed that the screen‐and‐treat strategy was cost‐effective even under assumptions of reduced adherence to drug therapy, reduced fracture reduction benefit from alendronate therapy, or reduced QALYs saved by preventing fracture. Conclusion: Universal bone densitometry combined with alendronate therapy for those found to have osteoporosis is highly cost‐effective for women aged 65 and older and may be cost saving for ambulatory women aged 85 and older (whether independently living or residing in nursing homes).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · doi:10.1097/00005650-199711000-00002 · Cited by 4,544
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443 · cited 2×
“The risks for each type of fracture as a function of age were developed from comprehensive population-based age-specific data for women from the Rochester Epidemiology Project,17 which captures virtually all healthcare utilization within Olmsted County, Minnesota.18 The incidence rates for clinical vertebral, hip, and…”
MethodSelf-citationUpdated Data on Proximal Femur Bone Mineral Levels of US Adults
Looker, A. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., Johnston Jr, C. C., & Lindsay, R. (1998) · Osteoporosis International · doi:10.1007/s001980050093 · Cited by 1,121 · cited 3×
“00554 g/cm(2) per year.(22) the relative risks of hip, vertebral, distal forearm, and other fractures were estimated for each change of T-score of 1 to be 2.”
BackgroundInfluential
Cited by
Priorities Among Effective Clinical Preventive Services
Maciosek, M. V., Coffield, A. B., Edwards, N. M., Flottemesch, T. J., Goodman, M. J., & Solberg, L. I. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.03.012 · Cited by 625
Cost-effective osteoporosis treatment thresholds: the United States perspective
Tosteson, A. N. A., Melton, L. J., Dawson-Hughes, B., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0550-6 · Cited by 441
“no intervention) in older white women in this country highlighted the potential value of screen and treat strategies [36].”
BackgroundSelf-citationImplications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA
Dawson-Hughes, B., Tosteson, A. N. A., Melton, L. J., Baim, S., Favus, M. J., Khosla, S., & Lindsay, R. L. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0559-5 · Cited by 427
“This conclusion is supported by another recent cost-effectiveness analysis using US data [48] and has been endorsed by the US Preventive Services Task Force [4].”
MethodSelf-citationGender Differences in Osteoporosis and Fractures
Cawthon, P. M. (2011) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-011-1780-7 · Cited by 311
Is Osteoporosis Disease Management Cost Effective?
Dell, R., & Greene, D. (2010) · Current Osteoporosis Reports · doi:10.1007/s11914-010-0009-0 · Cited by 54
Metadata
- Authors
- Schousboe, J. T., Ensrud, K. E., Nyman, J. A., Melton, L. J., & Kane, R. L.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2005-09-21
- Volume
- 53
- Issue
- 10
- Pages
- 1697-1704
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1916651944
- Cited by
- 94
- References
- 5
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Universal Bone Densitometry Screening Combined with Alendronate Therapy for Those Diagnosed with Osteoporosis Is Highly Cost‐Effective for Elderly Women. https://app.cochat.ai/papers/10.1111/j.1532-5415.2005.53504.x
- The paper
- Schousboe, J. T., Ensrud, K. E., Nyman, J. A., Melton, L. J., & Kane, R. L. (2005). Universal Bone Densitometry Screening Combined with Alendronate Therapy for Those Diagnosed with Osteoporosis Is Highly Cost‐Effective for Elderly Women. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.53504.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.